[Control of tuberculosis in relation to the HIV/AIDS epidemic. Work Group at the Secretariat of the National Plan on AIDS].
On April 7, 1999, the Monographic Meeting on HIV Infection and Tuberculosis was held at the Secretariat of the National AIDS Plan for the purpose of setting out certain clinical and health care policy recommendations concerning the control of tuberculosis (TB) with regard to the HIV infection epidemic, those in attendance being listed in Appendix 1. This meeting was organized into a number of presentations of papers (Appendix 2) grouped into four subject areas, which were followed by the pertinent debates. These four areas were as follows: 1. Epidemiology of the Dual HIV-TB Infection. 2. Treatments to Combat TB. 3. TB Prevention. 4. Health Care/TB Control Programs. The papers presented regarding a review of current literature focused on the search for scientific evidence with regard to treating and preventing TB among HIV-positive patients. The rest of the papers presented were: 1) regarding epidemiological topics 2) regarding results of different TB control programs and 3) regarding the analysis of the international and national recommendations concerning TB treatments and prevent among HIV-positive patients. Following the meeting, this report has been prepared as a summary thereof and was revised by all those who were in attendance at the meeting, the goal of which is that of setting out some recommendations for health care control and clinical handling of the dual Mycobacterium tuberculosis and HIV infection. This report provides no systematic or sufficiently detailed review of the different topics analyzed, therefore opting with regard to the bibliography to recommend a number of brief articles and reference books as a general source for further consultation. In this report, the term of "dual" TB-HIV infection is used generally and, in others the more specific "dual TB-AIDS disease", depending upon the presence of infection or disease caused by M. Tuberculosis and also AIDS, therefore, in the latter case.
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology / Q000517:prevention & control*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000453:epidemiology*; D000328:Adult; D000368:Aged; D000465:Algorithms; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004196:Disease Outbreaks; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D015995:Prevalence; D011446:Prospective Studies; D012189:Retrospective Studies; D013030:Spain / Q000453:epidemiology; D013997:Time Factors; D014376:Tuberculosis / Q000453:epidemiology / Q000517:prevention & control*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000517:prevention & control
D019380:Anti-HIV Agents; D000995:Antitubercular Agents